Search Results - "Showell, Graham A"

Refine Results
  1. 1

    Exploitation of silicon medicinal chemistry in drug discovery by Mills, John S, Showell, Graham A

    Published in Expert opinion on investigational drugs (01-09-2004)
    “…There remains considerable pressure on the pharmaceutical industry to increase productivity and reduce the attrition of drug candidates. Genomics, parallel…”
    Get more information
    Journal Article
  2. 2

    Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: A new use of silicon bioisosteres in medicinal chemistry by Barnes, Matthew J., Conroy, Richard, Miller, David J., Mills, John S., Montana, John G., Pooni, Parminder K., Showell, Graham A., Walsh, Louise M., Warneck, Julie B.H.

    Published in Bioorganic & medicinal chemistry letters (15-01-2007)
    “…The synthesis, physicochemical properties and pharmacological profiles of two novel silicon-containing p38 MAP kinase inhibitors are described. The synthesis,…”
    Get full text
    Journal Article
  3. 3

    Chemistry challenges in lead optimization: silicon isosteres in drug discovery by Showell, Graham A, Mills, John S

    Published in Drug Discovery Today (15-06-2003)
    “…During the lead optimization phase of drug discovery projects, the factors contributing to subsequent failure might include poor portfolio decision-making and…”
    Get full text
    Book Review Journal Article
  4. 4

    Sila-venlafaxine, a Sila-Analogue of the Serotonin/Noradrenaline Reuptake Inhibitor Venlafaxine:  Synthesis, Crystal Structure Analysis, and Pharmacological Characterization by Daiss, Jürgen O, Burschka, Christian, Mills, John S, Montana, John G, Showell, Graham A, Warneck, Julie B. H, Tacke, Reinhold

    Published in Organometallics (27-02-2006)
    “…The serotonin/noradrenaline reuptake inhibitor rac-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol (rac-venlafaxine, rac-1a) is in clinical use…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors by Street, Leslie J, Baker, Raymond, Book, Tracey, Kneen, Clare O, MacLeod, Angus M, Merchant, Kevin J, Showell, Graham A, Saunders, John, Herbert, Richard H

    Published in Journal of medicinal chemistry (01-10-1990)
    “…The synthesis and biochemical evaluation of novel 1,2,4-oxadiazole-based muscarinic agonists which can readily penetrate into the CNS is reported. Efficacy and…”
    Get full text
    Journal Article
  7. 7

    ( R)-Sila-venlafaxine: A selective noradrenaline reuptake inhibitor for the treatment of emesis by Showell, Graham A., Barnes, Matthew J., Daiss, Jürgen O., Mills, John S., Montana, John G., Tacke, Reinhold, Warneck, Julie B.H.

    Published in Bioorganic & medicinal chemistry letters (01-05-2006)
    “…The in vitro profile and in vivo anti-emetic activity of the selective noradrenaline reuptake inhibitor ( R )- 2 are reported. Sila-substitution of drugs (the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3) by Boyle, Robert G., Humphries, John, Mitchell, Tim, Showell, Graham A., Apaya, Robert, Iijima, Hiroaki, Shimada, Hiroshi, Arai, Tomonori, Ueno, Hiroaki, Usui, Yoshihiro, Sakaki, Toshiro, Wada, Etsuko, Wada, Keiji

    Published in Journal of peptide science (01-03-2005)
    “…Extensive SAR studies on the unselective BRS3 agonist, [H‐D‐Phe6,β‐Ala11,Phe13,Nle14]‐bombesin‐(6‐14)‐nonapeptide amide, have highlighted structural features…”
    Get full text
    Journal Article
  10. 10

    Synthesis and antihypertensive activity of 6,7-disubstituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ols by Evans, John M, Fake, Charles S, Hamilton, Thomas C, Poyser, Robert H, Showell, Graham A

    Published in Journal of medicinal chemistry (01-09-1984)
    “…A series of novel 6,7-disubstituted trans-3,4-dihydro-2, 2-dimethyl-4-pyrrolidino-(or piperidino)-2H-1-benzopyran-3-ols was prepared and tested for…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Thyroid hormone analogs. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart by Leeson, Paul D, Ellis, David, Emmett, John C, Shah, Virendra P, Showell, Graham A, Underwood, Anthony H

    Published in Journal of medicinal chemistry (01-01-1988)
    “…Twenty-nine novel 3'-substituted derivatives of the thyroid hormone 3,3',5-triiodo-L-thyronine (T3) have been synthesized by using established methods and by a…”
    Get full text
    Journal Article
  13. 13

    Synthesis and in vitro biological profile of all four isomers of the potent muscarinic agonist 3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo[2.2.1]heptane by Showell, Graham A, Baker, Raymond, Davis, Juliet, Hargreaves, Richard, Freedman, Stephen B, Hoogsteen, Karst, Patel, Shailendra, Snow, Roger J

    Published in Journal of medicinal chemistry (01-03-1992)
    “…The four stereoisomers of the muscarinic agonist 7 have been synthesized from enantiomerically pure exo-azanorbornane esters (13a,b). The esters were obtained…”
    Get full text
    Journal Article
  14. 14

    Selective thyromimetics. Cardiac-sparing thyroid hormone analogs containing 3'-arylmethyl substituents by Leeson, Paul D, Emmett, John C, Shah, Virendra P, Showell, Graham A, Novelli, Ricardo, Prain, H. Douglas, Benson, Martin G, Ellis, David, Pearce, Nigel J, Underwood, Anthony H

    Published in Journal of medicinal chemistry (01-02-1989)
    “…Introduction of specific arylmethyl groups at the 3'-position of the thyroid hormone 3,3',5-triiodo-L-thyronine (T3), and its known hormonally active…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    2-Methyl-1,3-dioxaazaspiro[4.5]decanes as novel muscarinic cholinergic agonists by Saunders, John, Showell, Graham A, Snow, Roger J, Baker, Raymond, Harley, Elizabeth A, Freedman, Stephen B

    Published in Journal of medicinal chemistry (01-02-1988)
    “…Many nonquaternary ammonium muscarinic agonists have been developed over the last few years, but most of the existing compounds (e.g., arecoline, RS-86, AF-30)…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Binding of 2,4-disubstituted morpholines at human D 4 dopamine receptors by Showell, Graham A., Emms, Frances, Marwood, Rosemarie, O'Connor, Desmond, Patel, Smita, Leeson, Paul D.

    Published in Bioorganic & medicinal chemistry (1998)
    “…The synthesis of a series of 2,4-disubstituted morpholines is described and their affinities at human dopamine receptors reported. The orally bioavailable…”
    Get full text
    Journal Article
  20. 20

    Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor by Bourrain, S, Collins, I, Neduvelil, J G, Rowley, M, Leeson, P D, Patel, S, Emms, F, Marwood, R, Chapman, K L, Fletcher, A E, Showell, G A

    Published in Bioorganic & medicinal chemistry (01-10-1998)
    “…Two novel series of 3-(heterocyclylmethyl)pyrazoles have been synthesised and evaluated as ligands for the human dopamine D4 receptor. Compounds in series I…”
    Get full text
    Journal Article